search
Back to results

Cryoanalgesia vs. Epidural in the Nuss Procedure

Primary Purpose

Pectus Excavatum, Funnel Chest

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Cryoanalgesia
Thoracic epidural (ropivicaine, fentanyl)
Sponsored by
University of California, San Francisco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pectus Excavatum focused on measuring Nuss, Nuss Procedure, pectus excavatum, cryoanalgesia

Eligibility Criteria

13 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • scheduled for Nuss procedure for pectus excavatum correction
  • at least 13 years old at the time of the procedure

Exclusion Criteria:

  • age less than 13 years at time of procedure
  • use of pain medication prior to procedure
  • pectus carinatum, Poland's syndrome, or any chest wall anomaly other than pectus excavatum
  • previous repair of pectus excavatum by any technique
  • previous thoracic surgery
  • congenital heart disease
  • bleeding dyscrasia
  • major anesthetic risk factors or history of previous problem with anesthesia
  • pregnancy
  • inability to communicate in English

Sites / Locations

  • UCSF-Benioff Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Cryoanalgesia

Thoracic Epidural

Arm Description

Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure

Thoracic epidural (ropivicaine, fentanyl).

Outcomes

Primary Outcome Measures

Length of Hospitalization
the length of the patient's in-hospital stay following admission for Nuss procedure

Secondary Outcome Measures

Narcotic Usage
Inpatient narcotic usage
Mean Neuropathic Pain Score at One Year
Neuropathic specific pain (described as "burning", "electrical" or "tingling" sensations) was assessed by study questionnaire via numerical pain scale (1 to 10, with 10 representing a maximum score, or worst pain possible).
Cost Analysis
cost analysis of initial hospitalization following Nuss procedure

Full Information

First Posted
March 22, 2016
Last Updated
May 3, 2021
Sponsor
University of California, San Francisco
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Food and Drug Administration (FDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT02721017
Brief Title
Cryoanalgesia vs. Epidural in the Nuss Procedure
Official Title
Pain Control in the Nuss Procedure: A Prospective, Randomized Trial of Cryoanalgesia vs. Thoracic Epidural
Study Type
Interventional

2. Study Status

Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
May 2016 (Actual)
Primary Completion Date
August 28, 2018 (Actual)
Study Completion Date
September 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Food and Drug Administration (FDA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether cryoanalgesia provides better pain control for minimally invasive pectus excavatum repair (the Nuss procedure) than thoracic epidural.
Detailed Description
Pain control is a major challenge for physicians, who must ensure appropriate and effective pain control for their patients, while remaining mindful of the many negative effects of opioid dependence and addiction. Nowhere is there a more pressing need than in children and young adults, who are at high risk for drug abuse, and in post-operative care, since post-operative opioid use can be a starting point for long-term pain issues. Postoperative pain control in the Nuss procedure, minimally invasive repair of the congenital chest wall deformity known as pectus excavatum, remains a significant problem for the 3000 patients who undergo this procedure each year, mostly adolescents and young adults. Many multimodal analgesic regimens have been tried, but optimal treatment remains unknown. This study will test a novel and promising strategy of using intra-operative cryoanalgesia during the Nuss procedure. Cryoanalgesia is the localized, temporary freezing of peripheral nerves, which is performed at the time of the Nuss procedure. The study is a 20-subject prospective, randomized pilot trial comparing cryoanalgesia to thoracic epidural analgesia for post-operative pain control in patients undergoing the Nuss procedure. Subjects will be recruited from patients already scheduled for a Nuss procedure at our institution, and will undergo 1:1 randomization to either cryoanalgesia or thoracic epidural analgesia for perioperative pain control. During their hospitalization, patients' opiate usage will be prospectively recorded, and pain will be assessed twice per day. Upon discharge, patients will maintain a log of their opiate use, and will return to clinic at 2 weeks, 1 month, 3 months, and 1 year after Nuss procedure for post-operative assessment. Primary outcome is length of perioperative hospitalization, an objective measure that synthesizes many different aspects of a procedure and its subsequent post-operative course, including pain control. Secondary outcomes are post-operative narcotic usage and direct cost of perioperative hospitalization. Side effects of both interventions will also be assessed. This will be the first systematic investigation of cryoanalgesia for local nerve block in a thoracoscopic procedure, and the first study involving its use in adolescents and young adults. The results will have direct application for those undergoing the Nuss procedure to repair pectus excavatum. Investigators will also delineate a reproducible protocol for delivering cryoanalgesia thoracoscopically, to ensure others can safely and effectively use this method if it proves beneficial. Although the focus is on the small subset of patients who undergo the Nuss procedure, if a standardized approach to cryoanalgesia delivery in a thoracoscopic procedure has a positive effect on patient outcomes and cost of hospitalization, the technique could be applied to a variety of surgical procedures, as well as for other neuropathic pain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pectus Excavatum, Funnel Chest
Keywords
Nuss, Nuss Procedure, pectus excavatum, cryoanalgesia

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cryoanalgesia
Arm Type
Experimental
Arm Description
Cryoanalgesia performed thoracoscopically under general anesthesia by the patient's surgeon at the time of the Nuss procedure
Arm Title
Thoracic Epidural
Arm Type
Active Comparator
Arm Description
Thoracic epidural (ropivicaine, fentanyl).
Intervention Type
Device
Intervention Name(s)
Cryoanalgesia
Other Intervention Name(s)
AtriCure, cryoprobe, nerve freezing
Intervention Type
Drug
Intervention Name(s)
Thoracic epidural (ropivicaine, fentanyl)
Other Intervention Name(s)
Epidural
Intervention Description
Epidural infusion was begun with with 0.1% ropivicaine and 2 mg/cc fentanyl.
Primary Outcome Measure Information:
Title
Length of Hospitalization
Description
the length of the patient's in-hospital stay following admission for Nuss procedure
Time Frame
estimated one week or less
Secondary Outcome Measure Information:
Title
Narcotic Usage
Description
Inpatient narcotic usage
Time Frame
Post Operative Hospital Stay
Title
Mean Neuropathic Pain Score at One Year
Description
Neuropathic specific pain (described as "burning", "electrical" or "tingling" sensations) was assessed by study questionnaire via numerical pain scale (1 to 10, with 10 representing a maximum score, or worst pain possible).
Time Frame
one year
Title
Cost Analysis
Description
cost analysis of initial hospitalization following Nuss procedure
Time Frame
estimated one week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
13 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: scheduled for Nuss procedure for pectus excavatum correction at least 13 years old at the time of the procedure Exclusion Criteria: age less than 13 years at time of procedure use of pain medication prior to procedure pectus carinatum, Poland's syndrome, or any chest wall anomaly other than pectus excavatum previous repair of pectus excavatum by any technique previous thoracic surgery congenital heart disease bleeding dyscrasia major anesthetic risk factors or history of previous problem with anesthesia pregnancy inability to communicate in English
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Benjamin Padilla, MD
Organizational Affiliation
415-370-2835
Official's Role
Principal Investigator
Facility Information:
Facility Name
UCSF-Benioff Children's Hospital
City
San Francisco
State/Province
California
ZIP/Postal Code
94158
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28341230
Citation
Graves C, Idowu O, Lee S, Padilla B, Kim S. Intraoperative cryoanalgesia for managing pain after the Nuss procedure. J Pediatr Surg. 2017 Jun;52(6):920-924. doi: 10.1016/j.jpedsurg.2017.03.006. Epub 2017 Mar 16.
Results Reference
background
PubMed Identifier
30935731
Citation
Graves CE, Moyer J, Zobel MJ, Mora R, Smith D, O'Day M, Padilla BE. Intraoperative intercostal nerve cryoablation During the Nuss procedure reduces length of stay and opioid requirement: A randomized clinical trial. J Pediatr Surg. 2019 Nov;54(11):2250-2256. doi: 10.1016/j.jpedsurg.2019.02.057. Epub 2019 Mar 17.
Results Reference
result

Learn more about this trial

Cryoanalgesia vs. Epidural in the Nuss Procedure

We'll reach out to this number within 24 hrs